Written Question·Department of Health and Social Care·UIN 18199

Clozapine

Tabled: 13 July 2026

Answered: 20 July 2026

Question

Lola McEvoy

To ask the Secretary of State for Health and Social Care, what steps the MHRA intends to take to consider patient and bereaved family lived experience as part of its current scientific review of Clozapine; and whether he is taking steps to ensure that liv

Answer

Preet Kaur Gill

The Medicines and Healthcare products Regulatory Agency (MHRA) confirms that in June 2026, the Neurology, Pain and Psychiatry Expert Advisory Group (NPPEAG) considered an assessment of clozapine drug level monitoring. The NPPEAG provided advice about the ...

ⓘ

This is an extract from the Parliament API. Search the full answer on Parliament.uk (UIN 18199) →